The latest news for pharma industry insiders.

Lucy Alexander, capabilities lead, global supply chain and strategy, AstraZeneca, discusses how to handle opposing concerns between supply chain teams and offers communication solutions.

The now-11-year odyssey to track drugs by item through the supply chain will be under a regulatory exemption for up to two years.

The latest news for pharma industry insiders.

Lucy Alexander, capabilities lead, global supply chain and strategy, AstraZeneca, discusses critical conversations that supply chain teams and partners must partake in during API sourcing at LogiPharma USA 2024.

A cohort study aims to connect the dots between incident AWVs among older adults with the first ADRD or MCI diagnosis who receive Medicare fee-for-service benefits.

The latest news for pharma industry insiders.

Lucy Alexander, capabilities lead, global supply chain and strategy, AstraZeneca, discusses key takeaways from the breakout session at LogiPharma USA 2024.

A deep dive into the future of patient service programs and the value of transparency throughout the process.

The latest news for pharma industry insiders.

With the implementation of unit-level traceability, the collaboration is expected to provide additional visibility not only within the aseptic manufacturing process, but the entire supply chain overall.

In this video interview with Pharma Commerce Editor Nicholas Saraceno, John Stefankiewicz, VP of Analytics, Cencora, describes the value of advocacy and other solutions in under-served areas.

The latest news for pharma industry insiders.

In the final part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Jenni Zilka, SVP, community & specialty pharmacy and president, Good Neighbor Pharmacy, explains how pending legislation can improve patient access, and how these are helping with recognizing pharmacists as HCPs.

The hub is intended to assist customers with achieving better sustainability by providing the necessary tools to do so.

The latest news for pharma industry insiders.

In this video interview with Pharma Commerce Editor Nicholas Saraceno, John Stefankiewicz, VP of Analytics, Cencora, details why these pharmacy deserts have become so widespread.

The goal is to provide greater access to HIV prevention drugs in low-income countries.

The latest news for pharma industry insiders.

Why it's critical for companies to set long-term, strategic goals in their journeys toward decarbonization.

In this video interview with Pharma Commerce Editor Nicholas Saraceno, Jenni Zilka, SVP, community & specialty pharmacy and president, Good Neighbor Pharmacy, clarifies the meaning behind pharmacy deserts, along with reasons for their increase in prominence.

Building strategy, mitigating risk, and achieving success with artificial intelligence.

The latest news for pharma industry insiders.

When it comes to navigating the complex clinical and commercial landscape for specialty drugs—including hurdles in access to these critical but costly therapies—today’s specialty pharmacies are bringing more skills and services to the table.

New facilities are expected to focus on manufacturing next-generation medicines and biologic medicines.